why choose us

First received: May 26, 2023

Clinical Trial: SGLT2 for Heart Failure in CHD Patients

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Heart Failure

Study Type: OBSERVATIONAL


Official Title: SGLT2 Inhibitors in Adult Patients With Heart Failure Related to Congenital Heart Disease

Brief Summary: Heart failure (HF) in adult patients with congenital heart disease is a major cause of morbidity and mortality.Approximately 30% of patients with significant congenital heart disease will develop signs of heart failure.Heart failure leads to hospitalization and disability with a longer hospital stay and higher health care costs as compared to heart failure patients without congenital heart disease.One-third of deaths in patients with congenital heart disease are attributable to heart failure.In patients with heart…

Read more